drugset / Trial / NCT00591357

Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy

NCT00591357

Phase 4 Suspended 120 enrolled Michael E. DeBakey VA Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To determine whether symptomatic treatment of the diarrhea in CDAD reduces morbidity and mortality of this serious nosocomial infection in patients who have antibiotic-associated diarrhea. Both C. diff positive and negative patients will be included.

Timeline

Start
2007-10
Primary completion
2013-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Loperamide Small molecule 2 mg Oral